Этиология, патогенез и методы определения ургентного мочеиспускания


Цитировать

Полный текст

Аннотация

Об авторах

Д Ю Пушкарь

Московский государственный медико-стоматологический университет

Кафедра урологии; Московский государственный медико-стоматологический университет

А В Зайцев

Московский государственный медико-стоматологический университет

Кафедра урологии; Московский государственный медико-стоматологический университет

П И Раснер

Московский государственный медико-стоматологический университет

Кафедра урологии; Московский государственный медико-стоматологический университет

Г Р Касян

Московский государственный медико-стоматологический университет

Кафедра урологии; Московский государственный медико-стоматологический университет

К Б Колонтарев

Московский государственный медико-стоматологический университет

Кафедра урологии; Московский государственный медико-стоматологический университет

Список литературы

  1. Abrams P., Wein A. J. The overactive bladder: from basic science to clinical management. Urology 1997; 50 (suppl. 6A): 1-144.
  2. Abrams P., Cardozo L., Fall M. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. and Urodyn. 2002; 21: 167-178.
  3. Stewart W. F., Van Rooyen J. B., Cundiff G. W. et al. Prevalence and burden of overactive bladder in the United States. World J. Urol. 2003; 20: 327-336.
  4. Milsom I., Abrams P., Cardozo L. et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br. J. Urol. Int. 2001; 87: 760-766.
  5. Liberman J. N., Hunt T. L., Stewart W. F. et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U. S. community based survey. Urology 2001; 57: 1044-1050.
  6. Zinner N., Noe L., Rasouliyan L. et al. Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Curr. Med. Res. Opin. 2008; 24 (6): 1583-1594.
  7. Chappie C. R., Artibani W., Cardozo L. D. et al. The role of urinary urgency and its measurement in the overactive bladdex symptom syndrome: Current concepts and future prospects. Br. J. Urol. Int. 2005; 95: 335-340.
  8. Athwal B. S., Berkley K. J., Hussain I. et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain 2001; 124: 369-377.
  9. de Groat W. C. A neurologic basis for the overactive bladder. Urology 1997; 50: 36-52; discus.: 53-56.
  10. Drake M. J., Harvey I. J., Gillespie J. I. et al. Localized contractions in the normal human bladder and in urinary urgency. Br. J. Urol. Int. 2005; 95: 1002-1005.
  11. Turner W. H., Brading A. F. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol.Ther. 1997; 75: 77-110.
  12. Coolsaet B. L., Van Duyl W. A., Van Os-Bossagh P. et al. New concepts in relation to urge and detrusor activity. Neurourol. and Urodyn. 1993; 12: 463-471.
  13. Drake M. J., Mills I. W., Gillespie J. I. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001; 358: 401-403.
  14. de Groat W. C. The urothelium in overactive bladder: Passive bystander or active participant? Urology 2004; 64: 7-11.
  15. Brubaker L. Urinary urgency and frequency: What should a clinician do? Obstetr. and Gynecol. 2005; 105: 661-667.
  16. Greenberg P., Brown J., Yates T. et al. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol. and Urodyn. 2008; 27 (4): 287-290.
  17. Abrams P. Urgency: Thefey to defining the overactive bladder. Br. J. Urol. Int. 2005; 96: 1-3.
  18. Barber M. D. Questionnaires for women with pelvic floor disorders. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007; 18: 461-465.
  19. Abrams P., Artibani W., Cardozo L. et al. Reviewing the ICS 2002 terminology report: The ongoing debate. Neurourol. and. Urodyn. 2006; 25: 293.
  20. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Note for guidlance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women. London, November 2002.
  21. Cardozo L., Coyne K. S., Versi E. Validation of the urgency perception scale. Br. J. Urol. Int. 2005; 95: 591-596.
  22. Blaivas J. G., Panagopoulos G., Weiss J. P. et al. The urgency perception score: Validation and test-retest. J. Urol. (Baltimore) 2007; 77: 199-202.
  23. Nixon A., Colman S., Sabounjian L. et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J. Urol. (Baltimore) 2005; 174: 604-607.
  24. Lukacz E. S., Lawrence J. M., Burchette R. J. et al. The use of Visual Analog Scale in urogynecologic research: A psychometric evaluation. Am. J. Obstetr. Gynecol. 2004; 191: 165-170.
  25. Coyne K., Matza L. S., Versi E. Urinary urgency: Can "gotta go" be measured? Jn: The 10th Annual meeting of the International Society for Quality of Life Research. Prague; 2003.
  26. Freeman R. M. How urgent is urgency? A review of current methods of assessment. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2005; 16: 93-95.
  27. Zinner N., Harnett M., Sabounjian L. et al. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J. Urol. (Baltimore) 2005; 173: 1639-1643.
  28. Yamaguchi O., Honda K., Nomiya M. Neurourol. and Urodyn. (Baltimore) 2007; 26 (suppl. 6): 904-907.
  29. Wein A. J. Urgency: The cornerstone symptom of overactive bladder. J. Urol. (Baltimore) 2005; 173: 2054.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2010

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах